Ocular Therapeutix, Inc. (OCUL)
9.46
+0.50
(+5.64%)
USD |
NASDAQ |
Feb 25, 13:00
Ocular Therapeutix Shareholders Equity (Annual) : 654.31M for Dec. 31, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Boston Scientific Corp. | 24.23B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| EyePoint Plc | 336.50M |
| Vertex Pharmaceuticals, Inc. | 18.67B |